Cargando…

Circumvention of Daunorubicin Resistance by a New Tamoxifen Derivative, Toremifene, in Multidrug‐resistant Cell Line

The reversing effect of toremifene, a new tamoxifen derivative, on multidrug resistance in a K562 subline and its mechanism were studied. K562 cells were cultured in serially increasing concentrations up to 1.0 μM daunorubicin (DNR), and were found to be 28 times more resistant to DNR in comparison...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urasaki, Yoshimasa, Ueda, Takanori, Nakamura, Toru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1994
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919521/ https://www.ncbi.nlm.nih.gov/pubmed/7914886 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02410.x

Ejemplares similares

Circumvention of Atypical Multidrug Resistance with Tumor Necrosis Factor
por: Cimoli, Guido, et al.
Publicado: (1994)

Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
por: Julia, A. M., et al.
Publicado: (1994)

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
por: Hachisuga, T, et al.
Publicado: (2005)

Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women
por: Marttunen, M B, et al.
Publicado: (2001)

Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer
por: Song, Dandan, et al.
Publicado: (2021)

Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.
por: Merry, S., et al.
Publicado: (1989)

Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention.
por: Supino, R., et al.
Publicado: (1986)

Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer
por: To, Kenneth K.W., et al.
Publicado: (2016)

Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.
por: McGown, A., et al.
Publicado: (1987)

A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis
por: Hong, Jin, et al.
Publicado: (2020)

Interaction of tamoxifen with the multidrug resistance P-glycoprotein.
por: Callaghan, R., et al.
Publicado: (1995)

Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
por: Chai, Stella, et al.
Publicado: (2010)

Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
por: Sehested, M., et al.
Publicado: (1990)

Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients: A network meta-analysis
por: He, Tao, et al.
Publicado: (2020)

Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016)

High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
por: Mori, Ryutaro, et al.
Publicado: (2014)

Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML
por: Sargent, J M, et al.
Publicado: (2001)

Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting
por: Zhou, Minglu, et al.
Publicado: (2019)

Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
por: Sehested, M., et al.
Publicado: (1989)

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
por: PyrhÃ¶nen, S., et al.
Publicado: (1997)

SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
por: Loor, F., et al.
Publicado: (1992)

Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil.
por: Merry, S., et al.
Publicado: (1987)

Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.
por: Merry, S., et al.
Publicado: (1986)

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.
por: Holford, J., et al.
Publicado: (1998)

Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen
por: Wang, Hongyue, et al.
Publicado: (2021)

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987)

Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene
por: Balducci, Chiara, et al.
Publicado: (2005)

Impact of Stepwise NH(2)-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention
por: Kowol, Christian R., et al.
Publicado: (2016)

Circumvention of 5‐Fluorouracil Resistance in Human Stomach Cancer Cells by Uracil Phosphoribosyltransferase Gene Transduction
por: Inaba, Makoto, et al.
Publicado: (1999)

Daunorubicin resensitizes Gram-negative superbugs to the last-line antibiotics and prevents the transmission of antibiotic resistance
por: Cai, Jinju, et al.
Publicado: (2023)

Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
por: Zhou, Yi, et al.
Publicado: (2016)

Peutz-Jeghers Syndrome: A Circumventable Emergency
por: Choudhury, Sourav, et al.
Publicado: (2018)

Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.
por: Slater, L. M., et al.
Publicado: (1986)

Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia.
por: Smith, B. J., et al.
Publicado: (1976)

Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells
por: Codini, Michela, et al.
Publicado: (2018)

5′‐Deoxy‐S‐fluorouridine Increases Daunorubicin Uptake in Multidrug‐resistant Cells and Its Activity Is Related with P‐gp 170 Expression
por: van der Heyden, Sylke, et al.
Publicado: (1994)

Reversal of multidrug resistance by magnetic Fe(3)O(4) nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice
por: Chen, Baoan, et al.
Publicado: (2009)

Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)

Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study
por: Gu, Ran, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vo54v1crdqahrbspqnljtc621j